The angiotensin II receptor antagonists are the most selective blockers of the renin-angiotensin system currently available. The efficacy of these drugs is similar to that of the other major antihypertensive drug classes, but they appear to exhibit fewer side effects. Angiotensin receptor blockers selectively block the angiotensin AT1 receptors, leaving AT2 receptors exposed to increased [...]
